 - All other DMARDs or biologics must be discontinued at least 28 days prior to study drug administration and: 1 Leflunomide, which must be discontinued at least 60 days before study drug administration, 2 infliximab, adalimumab, and abatacept must be discontinued at least 56 days prior to study drug administration 